Prevalence of Asthma Symptoms in 13-14-Year-Old Adolescents in Karaj
Abstract
Asthma is the most common chronic inflammatory respiratory disorder in children. This study was designed to assess the prevalence of asthma in 13-14-year-old adolescents in Karaj, Alborz province in Iran, using the international study of asthma and allergies in childhood (ISAAC) questionnaire. Totally 950 adolescents attending 40 schools located in 4 regions of Karaj city were enrolled in the survey. The Persian version of the ISAAC questionnaire was filled by 13-14-year-old students. Multi-stage clustered random sampling was used to divide the city of Karaj into four educational districts. Ever wheezing was reported in 22% of the individuals; 10.52% claimed to have wheeze in the last 12 months and 22.73% had during or after exercise. The experience of wheezing in the last 12 months was more prevalent among males (11.73% vs. 9.38%; p<0.05). However, having a history of asthma was higher among males (7.55% vs. 3.47%; p<0.05). History of hospitalization (60.8%), family history of asthma (49.4%), and history of food allergy (42.3%) were found to be the most frequent characteristics significantly associated with" ever wheezing" (p<0.05). The prevalence of wheezing in the last 12 months, as a major index of current asthma, was 10% which was close to the national average. However, nocturnal cough and exercise-induced wheezing were higher in Karaj compared to other cities of Iran; which could be related to the high level of air pollution in this industrial area.
2. D’Amato G, Vitale C, Molino A, Stanziola A, Sanduzzi A, Vatrella A, et al. Asthma-related deaths. Multidiscip Respir Med. 2016;11(1):37.
3. Mazurek JM, Syamlal G. Prevalence of asthma, asthma attacks, and emergency department visits for asthma among working adults—National Health Interview Survey, 2011–2016. Morbidity and Mortality Weekly Report. 2018;67(13):377.
4. Fazlollahi MR, Najmi M, Fallahnezhad M, Sabetkish N, Kazemnejad A, Bidad K, et al. The prevalence of asthma in Iranian adults: the first national survey and the most recent updates. Clin Respir J. 2018;12(5):1872-81.
5. Kiboneka A, Levin M, Mosalakatane T, Makone I, Wobudeya E, Makubate B, et al. Prevalence of asthma among school children in Gaborone, Botswana. Afr Health Sci. 2016;16(3):809-16.
6. Dharmage SC, Perret J, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246.
7. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62(9):758-66.
8. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009;64(6):476-83.
9. Beasley R, of Asthma TIS. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351(9111):1225-32.
10. Lawshe CH. A quantitative approach to content validity. Personnel psychology. 1975;28(4):563-75.
11. Signs V. Asthma prevalence, disease characteristics and self-management education–United States, 2001-2009. MMWR Morb Mortal Wkly Rep. 2011;6(17):547-52.
12. Shakurnia AH, Assar S, Afra M, Latifi M. Prevalence of asthma among schoolchildren in Ahvaz, Islamic Republic of Iran. 2010.
13. Mortazavi Moghadam SGR, Sadat Jou SAR. Prevalence oof asthma symptoms among 13-14 years old children in Birjand. Zahedan Journal of Research in Medical Sciences (Tabib-E-Shargh). 2004;6(3):183-92.
14. Gooya M, Shirkani A, Tahmasebi R, Omrani A, Gheybi MK, Darabi H, et al. Prevalence of Asthma and Allergic Diseases and Its Risk Factors in School Children Aged (6-7 and 13-14 Years) in Assalouyeh City, Bushehr Province Based on III ISAAC Protocol Phase I, in 2014. BPUMS. 2017;20(1):57-69.
15. Kalmarzi R, Shekari A, Tajik M, Ataee P, Homagostar G, Roshani D, et al. The Prevalence of Asthma Symptoms in Elementary and Middle School Students in Kurdistan Province, the West of Iran. 2016;4.
16. Fazlollahi MR, Najmi M, Fallahnezhad M, Sabetkish N, Kazemnejad A, Bidad K, et al. Paediatric asthma prevalence: The first national population-based survey in Iran. Clin Respir J. 2019;13(1):14-22.
17. Abbasi Ranjbar Z. Prevalence of asthma symptoms in children. J Guilan University of Medical Sciences. 2006;14(56):1-9.
18. Bazazi H, Gharagozlou M, Kassai M, Zahmatkesh H, Parsikia A. The prevalence of asthma and allergic disorders among school children in Gorgan. J Research In Medical Sciences (JRMS). 2007;12(1):28-33.
19. Mirzaei M, Karimi M, Beheshti S, Mohammadi M. Prevalence of asthma among Middle Eastern children: A systematic review. Med J Islam Repub Iran. 2017;31:9.
20. Masoli M, Fabian D, Holt S, Beasley R. Global Burden of Asthma, Allergy 59(5):469-78.
21. Zohal MA, Hasheminasab R. Prevalence of asthma among school-age children in Qazvin (2003. JQUMS. 2006;9(4):64-8.
22. Wong GW, Leung TF, Ko FW. Changing prevalence of allergic diseases in the Asia-pacific region. Allergy Asthma Immunol Res. 2013;5(5):251-7.
23. Fazlollahi MR, Abbasi JM, Dana VG, Yousefzade A, Sabetkish N, Haghighat S. Evaluation of allergic symptoms prevalence and its relationship with acetaminophen/antibiotic use and hospitalization among school-aged children in Tehran, Iran. Iranian Red Crescent Medical Journal. 2017;19(5).
24. Fadaeizadeh L, Salek S, Najafizadeh K, Masjedi MR. Prevalence and severity of asthma symptoms in students of Tehranand Rasht: phaseIII ISAAC study. Tanaffos. 2008;7(3):31-6.
25. Zobeiri M. Prevalence, risk factors and severity of asthma symptoms in children of Kermanshah, IRAN: ISAAC phase I, II. Acta Med Iran. 2011;49(3):184-8.
Files | ||
Issue | Vol 19 No 6 (2020) | |
Section | Brief Communication | |
DOI | https://doi.org/10.18502/ijaai.v19i6.4935 | |
PMID | 33463135 | |
Keywords | ||
Asthma Child Iran Prevalence |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |